Floatz logo

Epoetin Beta

Unspecified Adult Solid Tumor, Protocol Specific

Institut du Cancer de Montpellier - Val d'Aurelleprotein_peptidePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

18 Active assets in the Unspecified Adult Solid Tumor, Protocol Specific cohort.

Asset / SponsorPhaseRating
NEPENTHE
M.D. Anderson Cancer Center
Phase 4BBB
Amifostine
M.D. Anderson Cancer Center
Phase 4BBB
DEXAMETHASONE
Alliance for Clinical Trials in Oncology
Phase 3BBB
ETOPOSIDE
University of California, Davis
Phase 2/3BBB
Eloxatin
Alliance for Clinical Trials in Oncology
Phase 2BBB

View all 50 →

Same molecule, other indications

Epoetin Beta is also rated in:

anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
plasma cell myelomaDormant
B
Indicative ·
60 / 100
View asset →
leukemiaDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →